Lodz, Poland

Slawomira Pilichowska


Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Slawomira Pilichowska: Innovator in Antitumor Research

Introduction

Slawomira Pilichowska is a notable inventor based in Lodz, Poland. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with antitumor activity. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to advancing medical science.

Latest Patents

Slawomira Pilichowska holds a patent for a process related to the production of 1,3,2-oxazaphosphorinanes. This process involves the production of derivatives of 1,3,2-oxazaphosphorinane, where specific chemical groups are manipulated to create compounds that demonstrate antitumor activity. The method utilizes sodium borohydride in the presence of boron trifluoride etherate to achieve the desired chemical transformations.

Career Highlights

Throughout her career, Slawomira has worked with esteemed organizations such as the Pharmaceutical Industry Institute and the Center for Molecular and Macromolecular Studies. Her work in these institutions has allowed her to collaborate with other experts in the field and contribute to significant advancements in pharmaceutical research.

Collaborations

Slawomira has collaborated with notable colleagues, including Wojciech J Stec and Czeslaw Radzikowski. These partnerships have enriched her research and expanded the impact of her innovations in the scientific community.

Conclusion

Slawomira Pilichowska's contributions to the field of pharmaceutical chemistry, particularly through her patented processes, highlight her role as an innovator in antitumor research. Her work continues to inspire advancements in medical science and demonstrates the importance of collaboration in achieving significant breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…